P3 Health Partners Inc. (PIII)
P3 Health Partners Statistics
Share Statistics
P3 Health Partners has 140.87M shares outstanding. The number of shares has increased by 0.38% in one year.
| Shares Outstanding | 140.87M |
| Shares Change (YoY) | 0.38% |
| Shares Change (QoQ) | 0.07% |
| Owned by Institutions (%) | 12.49% |
| Shares Floating | 79.07M |
| Failed to Deliver (FTD) Shares | 482 |
| FTD / Avg. Volume | 2.2% |
Short Selling Information
The latest short interest is 1.7M, so 0.47% of the outstanding shares have been sold short.
| Short Interest | 1.7M |
| Short % of Shares Out | 0.47% |
| Short % of Float | 0.84% |
| Short Ratio (days to cover) | 1.75 |
Valuation Ratios
The PE ratio is -0.24 and the forward PE ratio is -24.21. P3 Health Partners's PEG ratio is 0.
| PE Ratio | -0.24 |
| Forward PE | -24.21 |
| PS Ratio | 0.02 |
| Forward PS | 0.9 |
| PB Ratio | 0.43 |
| P/FCF Ratio | -0.3 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for P3 Health Partners.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.37, with a Debt / Equity ratio of 1.01.
| Current Ratio | 0.37 |
| Quick Ratio | 0.37 |
| Debt / Equity | 1.01 |
| Debt / EBITDA | -0.32 |
| Debt / FCF | -0.69 |
| Interest Coverage | -14.46 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $4.17M |
| Profits Per Employee | $-377.36K |
| Employee Count | 360 |
| Asset Turnover | 1.92 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 4.39M |
| Effective Tax Rate | -1.43% |
Stock Price Statistics
The stock price has increased by 2055.12% in the last 52 weeks. The beta is 0.95, so P3 Health Partners's price volatility has been higher than the market average.
| Beta | 0.95 |
| 52-Week Price Change | 2055.12% |
| 50-Day Moving Average | 3.94 |
| 200-Day Moving Average | 1.27 |
| Relative Strength Index (RSI) | 70.69 |
| Average Volume (20 Days) | 21.92K |
Income Statement
In the last 12 months, P3 Health Partners had revenue of 1.5B and earned -135.85M in profits. Earnings per share was -0.94.
| Revenue | 1.5B |
| Gross Profit | 1.5B |
| Operating Income | -320.66M |
| Net Income | -135.85M |
| EBITDA | -242.11M |
| EBIT | -328.16M |
| Earnings Per Share (EPS) | -0.94 |
Balance Sheet
The company has 38.82M in cash and 76.34M in debt, giving a net cash position of -37.52M.
| Cash & Cash Equivalents | 38.82M |
| Total Debt | 76.34M |
| Net Cash | -37.52M |
| Retained Earnings | -503.19M |
| Total Assets | 783.42M |
| Working Capital | -312.27M |
Cash Flow
In the last 12 months, operating cash flow was -110.13M and capital expenditures 0, giving a free cash flow of -110.13M.
| Operating Cash Flow | -110.13M |
| Capital Expenditures | 0 |
| Free Cash Flow | -110.13M |
| FCF Per Share | -0.76 |
Margins
Gross margin is 100%, with operating and profit margins of -21.37% and -9.05%.
| Gross Margin | 100% |
| Operating Margin | -21.37% |
| Pretax Margin | -20.39% |
| Profit Margin | -9.05% |
| EBITDA Margin | -16.14% |
| EBIT Margin | -21.37% |
| FCF Margin | -7.34% |
Dividends & Yields
PIII does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for PIII is $12.5, which is 22.9% higher than the current price. The consensus rating is "Hold".
| Price Target | $12.5 |
| Price Target Difference | 22.9% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
Scores
| Altman Z-Score | 2.4 |
| Piotroski F-Score | 3 |